# Reperio Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reperio-health

- Industry: Medical Devices & Equipment
- Headquarters: Portland, US
- Website: www.reperiohealth.com
- Total disclosed funding: $19M
- Latest round: Seed (May 19, 2025)
- Investors on record: 5

## About

Based in Oregon, US, Reperio Health, Inc. was founded in 2020 by co-founders Matt Wallington and Travis Rush. The company is an at-home health assessment and biometric screening system. Reperio Health raised its first funding in March 2021.

Reperio Health's services allow its customers to obtain at-home health testing with results, which include a phonocardiogram, that listens to and records the sound of the user's heart, and a blood test, that measures cholesterol, triglycerides, glucose, and lipids.

The company generates its revenue by subscribing through its kit and services.

The company plans to accelerate growth and expand proactive health monitoring to the employer market.

## Funding rounds

- Seed, May 19, 2025, $14M — Caduceus Capital Partners
- Seed, Feb 9, 2024, $1.6M — Portland Seed Fund, Rogue Venture Partners, Liquid 2 Ventures, Caduceus Capital Partners
- Seed, Mar 1, 2021, $3.2M — Portland Seed Fund, Rogue Venture Partners, Liquid 2 Ventures, Caduceus Capital Partners, G Ventures

## Investors

- Portland Seed Fund (https://capitalatlas.ai/funds/portland-seed-fund) — Seed
- Rogue Venture Partners (https://capitalatlas.ai/funds/rogue-venture-partners) — Seed
- Liquid 2 Ventures (https://capitalatlas.ai/funds/liquid-2-ventures) — Seed
- Caduceus Capital Partners (https://capitalatlas.ai/funds/caduceus-capital-partners) — Seed
- G Ventures (https://capitalatlas.ai/funds/g-ventures) — Seed